METHODS	In this randomized , placebo-controlled trial , we assessed the efficacy of lenograstim ( granulocyte colony-stimulating factor [ G-CSF ] , 263 mu g per day administered intravenously ) in ceftazidime-treated patients with severe sepsis caused by suspected melioidosis in Thailand .\